Synageva BioPharma raises $30 million

April 16th, 2009

Synageva BioPharma, a privately held biotechnology company, has announced a $30 million private equity financing. The financing was led by the New York-based private equity firm Baker Brothers Investments. Synageva’s Chairman of the Board, Felix Baker, is a managing partner at Baker Brothers.